| Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637) |
|---|
| 01/03/2013 | US20130004944 H5 Subtype-Specific Binding Proteins Useful for H5 Avian Influenza Diagnosis and Surveillance |
| 01/03/2013 | US20130004943 H5 Subtype-Specific Binding Proteins Useful for H5 Avian Influenza Diagnosis and Surveillance |
| 01/03/2013 | US20130004534 Inactivation of reverse transcriptases by azido-diarylpyrimidines |
| 01/03/2013 | US20130004529 Vaccines and methods for using the same |
| 01/03/2013 | US20130004497 Monoclonal antibodies specific to hemagglutinin and neuraminidase from influenza virus h5-subtype or n1-subtype and uses thereof |
| 01/03/2013 | US20130004496 Monoclonal antibodies specific to hemagglutinin and neuraminidase from influenza virus h5-subtype or n1-subtype and uses thereof |
| 01/03/2013 | US20130004461 Subfamily e simian adenoviruses a1321, a1325, a1295, a1309, a1316 and a1322 and uses thereof |
| 01/03/2013 | CA2839668A1 Epitope and its use of hepatitis b virus surface antigen |
| 01/03/2013 | CA2839506A1 Canine coronavirus vaccine |
| 01/02/2013 | EP2540312A1 Avian influenza chimeric VLPS |
| 01/02/2013 | EP2538972A1 Recombinant cdv compositions and uses thereof |
| 01/02/2013 | CN102858961A Novel method |
| 01/02/2013 | CN102858960A Plasmids and methods for peptide display and affinity-selection on virus-like particles of rna bacteriophages |
| 01/02/2013 | CN102858959A Oncolytic rhabdovirus |
| 01/02/2013 | CN102851316A Method for improving in-vitro expression of cytochrome P450 enzyme family |
| 01/02/2013 | CN102851258A Recombination influenza virus of high-efficiency-expression HA (hemagglutinin) protein and preparation method and application of recombination influenza virus |
| 01/02/2013 | CN102851257A Attenuated vaccine strain for avian infectious bronchitis virus and application thereof |
| 01/02/2013 | CN102206618B Salicornia europaea SeVHA-A protein and encoding gene and application thereof |
| 01/02/2013 | CN102181404B Recombinant adenovirus expressing E0, E2 gene of classical swine fever virus |
| 01/02/2013 | CN101899418B Avian influenza virus (AIV) as well as kit and vaccine used for detecting and preventing same |
| 01/02/2013 | CN101466720B Processes for packaging oligonucleotides into virus-like particles of RNA bacteriophages |
| 01/02/2013 | CN101148661B Human papilloma virus 16 type coat protein virus-like particles, preparation method and use thereof |
| 01/01/2013 | US8343718 Strain of SARS-associated coronavirus and applications thereof |
| 01/01/2013 | US8343506 Chimeric chikungunya virus and uses thereof |
| 12/27/2012 | WO2012177924A2 Influenza virus mutants and uses therefor |
| 12/27/2012 | WO2012145597A3 Recombinant virus products and methods for inhibition of expression of myotilin |
| 12/27/2012 | WO2012131008A3 Inactivation of bacteriophages in a liquid |
| 12/27/2012 | US20120331576 Pathogen Restriction Factors |
| 12/27/2012 | US20120329136 Methods and compositions for the production of recombinant virus vectors |
| 12/27/2012 | US20120329052 Identification of a dna variant associated with adult type hypolactasia |
| 12/27/2012 | US20120328652 Recombinant attenuated parvovirus |
| 12/27/2012 | US20120328651 Chimpanzee adenovirus vaccine carriers |
| 12/27/2012 | US20120328650 Modified vaccinia ankara virus variant |
| 12/27/2012 | US20120328649 Recombinant Viral Vectors and Methods for Inducing an Immune Response to Yellow Fever Virus |
| 12/27/2012 | DE102011105525A1 Verfahren zur Abtrennung von Biopolymer-Aggregaten und Viren aus einem Fluid A method for separating biopolymer aggregates and virus from a fluid |
| 12/27/2012 | CA2875484A1 Influenza virus mutants and uses therefor |
| 12/27/2012 | CA2834618A1 Hpv vaccine formulations comprising aluminum adjuvant and methods of producing same |
| 12/26/2012 | EP2536829A1 Method for the production of ad26 adenoviral vectors |
| 12/26/2012 | EP2536743A1 Human group p immunodeficiency virus and uses thereof |
| 12/26/2012 | CN102839183A Preparation method and application of recombinant enterovirus 71 type virus-like particle |
| 12/26/2012 | CN102839160A Recombination influenza virus of high-efficiency expression HA (Hyaluronic Acid) protein, as well as preparation method and application thereof |
| 12/26/2012 | CN102839159A CoxA16 virus strain and human CoxA16 inactivated vaccine |
| 12/26/2012 | CN102839158A Canine distemper attenuated vaccine strain and medical purpose |
| 12/26/2012 | CN102839157A MDCK cell system capable of stably coexpressing Hst3GIIV and beta1-4GalT1 and establishing method and application thereof |
| 12/26/2012 | CN102304496B Attenuated culture of high-pathogenic porcine reproductive and respiratory syndrome virus attenuated vaccine GDr strain |
| 12/26/2012 | CN102154220B Method and equipment for ultrahigh-density and large-scale production of porcine reproductive and respiratory syndrome virus (PRRSV) |
| 12/26/2012 | CN102094035B Expression vector for constructing high-quality bacteriophage antibody library |
| 12/26/2012 | CN102058882B Method of preparing hepatitis A inactivated vaccine |
| 12/26/2012 | CN101358203B Method for preparing membrane protein based on enveloped virus budding mode of insect |
| 12/25/2012 | US8338159 Chicken virus vaccine and diagnostic |
| 12/25/2012 | US8337860 Development of dengue virus vaccine components |
| 12/25/2012 | US8337859 Vectors for multiple gene expression |
| 12/20/2012 | WO2012171334A1 Method for transdifferentiating fibroblast into liver stem cell |
| 12/20/2012 | WO2012171328A1 Electrophoresis device and use thereof |
| 12/20/2012 | WO2012171104A1 Rabies virus like particle production in plants |
| 12/20/2012 | WO2012125005A3 Pol i promoter derived from vero cells and recombinant vector containing same |
| 12/20/2012 | WO2011138040A8 Vaccine against beta-herpesvirus infection and use thereof |
| 12/20/2012 | WO2009013324A9 Vector particles for targeting cd34+ cells |
| 12/20/2012 | US20120322981 Citrullination-specific phage display |
| 12/20/2012 | US20120321661 Recombinant Measles Virus Useful as a Bivalent Vaccine Against Measles and Malarial Infections |
| 12/20/2012 | US20120321659 Hbv core antigen particles with multiple immunogenic components attached via peptide ligands |
| 12/20/2012 | US20120321654 Infectious clones of torque teno virus |
| 12/20/2012 | US20120321599 Herpes virus strains |
| 12/20/2012 | US20120321590 Bridged polycyclic compounds |
| 12/20/2012 | CA2839009A1 Rabies virus like particle production in plants |
| 12/19/2012 | EP2535409A1 Method for producing recombinant virus |
| 12/19/2012 | EP2535405A1 A recombinant a/astanarg/6:2/2009 m-12-09/d flu virus strain produced by a reverse genetics method from a highly pathogenic donor strain a/chicken/astana/6/05 (h5n1) and a highly reproductive donor strain a/puerto rico/8/34 (h1n1) from the orthomyxoviridae family of the genus influenza virus type a which is deposited in the microorganism collection of the science committee at the ministry of education and science of the republic of kazakhstan state enterprise subsidiary of the scientific research institute for biological safety problems at the republican state enterprise of the national centre for biotechnology of the republic of kazakhstan and can be used in biotechnology for the production of diagnostic and vaccine preparations against a/h5n1 flu |
| 12/19/2012 | EP2535058A2 Stabilization of vaccines by lyophilization |
| 12/19/2012 | CN102834507A Construct for production of empty picornaviral capsids |
| 12/19/2012 | CN102827846A Preparation method and application of recombination coxsackie virus B3-type virus-like particles |
| 12/19/2012 | CN102824854A Electrophoresis apparatus and its application |
| 12/19/2012 | CN102443572B Method for purifying detoxified pertussis vaccine antigen solution |
| 12/19/2012 | CN102220293B Dog flu recombinant virus as well as preparation method and application thereof |
| 12/19/2012 | CN102154227B Chimeric virus of complete structural protein of hepatitis C virus and GB virus B |
| 12/19/2012 | CN102120988B Recombinant porcine circovirus type 2 strain expressing V5 epitope tag and application thereof |
| 12/19/2012 | CN102040658B Schistosoma japonica polypeptide with immunogenicity and application thereof |
| 12/18/2012 | US8334127 Bionanomaterials and their synthesis |
| 12/13/2012 | WO2012170997A1 Paramyxovirus immunogens and related materials and methods |
| 12/13/2012 | WO2012168818A1 Infectious clones of torque teno virus |
| 12/13/2012 | WO2012168480A1 Agents and methods for producing hiv-capsid derived non-infectious adjuvants |
| 12/13/2012 | WO2012167382A1 Compositions and methods for glioblastoma treatment |
| 12/13/2012 | US20120315686 Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides |
| 12/13/2012 | US20120315295 Development of a Marker Foot and Mouth Disease Virus Vaccine Candidate That is Attenuated in the Natural Host |
| 12/12/2012 | EP2532362A1 Vaccines including antigen from four strains of influenza virus |
| 12/12/2012 | EP2531592A1 Fed-batch process using concentrated cell culture medium for the efficient production of biologics in eb66 cells |
| 12/12/2012 | EP2531212A1 Bunyavirus vaccine |
| 12/12/2012 | CN102816742A Chimeric adenoviruses for use in cancer treatment |
| 12/12/2012 | CN102816741A Preparation method and application of newcastle disease virus living-vector vaccine through gene recombination of canine distemper attenuated vaccine strains F and H |
| 12/12/2012 | CN102816740A Avian influenza virus, inactivated vaccine and method for preparing same |
| 12/12/2012 | CN102816732A MDCK cell line suitable for full suspended serum-free culture and its application in culturing of influenza virus and production of influenza virus vaccines |
| 12/12/2012 | CN102816215A Smallish polypeptide capable of inhibiting HIV and medicinal use thereof |
| 12/12/2012 | CN102813919A Recombinant canine distemper vaccine for expressing hemagglutinin repeatedly and preparation method |
| 12/12/2012 | CN102286435B Regulatory-cytokine-induced anti-apoptotic molecule (CIAPIN1) recombinant adenovirus and preparation method and use thereof |
| 12/12/2012 | CN102000328B Method for manufacturing Marek's disease vaccine by utilizing cell factory |
| 12/12/2012 | CN101974489B A H1N1 influenza virus and application thereof |
| 12/12/2012 | CN101920012B Method for producing porcine circovirus type II recombinant capsid protein subunit vaccine by utilizing silkworm bioreactor and products thereof |
| 12/12/2012 | CN101400366B Hepatitis c virus non structural fusion protein |
| 12/12/2012 | CN101203613B Method of increasing the function of gland related viral vector |
| 12/11/2012 | US8329878 Methods for protein refolding |
| 12/11/2012 | US8329466 Method for the cultivation of primary cells and for the amplification of viruses under serum free conditions |